Childhood cancer and the Jehovah's Witness faith. (opens new window)

Frankel LS, Damme CJ, Eys JV.

Avots‎: Pediatrics 1977;60(6):916-21.

Raksts indeksēts‎: PubMed 600607

https://www.ncbi.nlm.nih.gov/pubmed/600607 (opens new window)

Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children's Oncology Group trial AAML0531. (opens new window)

Gamis AS, Alonzo TA, Meshinchi S, Sung L, Gerbing RB, Raimondi SC, Hirsch BA, Kahwash SB, Heerema-McKenney A, Winter L, Glick K, Davies SM, Byron P, Smith FO, Aplenc R

Avots‎: J Clin Oncol 2014;32(27):3021-32.

Raksts indeksēts‎: PubMed 25092781

DOI‎: 10.1200/JCO.2014.55.3628

https://www.ncbi.nlm.nih.gov/pubmed/25092781 (opens new window)

Red blood cell transfusion and outcome in cancer. (opens new window)

Iqbal N, Haider K, Sundaram V, Radosevic J, Burnouf T, Seghatchian J, Goubran H

Avots‎: Transfus Apher Sci 2017;56(3):287-90.

Raksts indeksēts‎: PubMed 28602484

DOI‎: 10.1016/j.transci.2017.05.014

https://www.ncbi.nlm.nih.gov/pubmed/28602484 (opens new window)

Bloodless cancer treatment results of patients who do not want blood transfusion: single center experience of 77 cases. (opens new window)

Oh SY, Kim SH, Kwon HC, Lee S, Kim KH, Kwon KA, Lee JH, Lee KY, Kim HJ

Avots‎: Support Care Cancer 2010;18(10):1341-6.

Raksts indeksēts‎: PubMed 19841950

DOI‎: 10.1007/s00520-009-0759-3

https://www.ncbi.nlm.nih.gov/pubmed/19841950 (opens new window)